Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (17493)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2015 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Attwa MH, El-Etreby SA. Guide for diagnosis and treatment of hepatocellular carcinoma. World J Hepatol 2015; 7(12): 1632-1651 [PMID: 26140083 DOI: 10.4254/wjh.v7.i12.1632] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i12/1632.htm |
| Number | Citing Articles |
| 1 |
Wenbing Sun, Shuqi Fu, Size Wu, Rong Tu, Diego Franco. Growing Evidence of Exosomal MicroRNA-Related Metastasis of Hepatocellular Carcinoma. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/4501454
|
| 2 |
Chen Han, Yongjie Jiang, Zhaoxia Wang, Hengxiao Wang. Natural killer cells involved in tumour immune escape of hepatocellular carcinomar. International Immunopharmacology 2019; 73: 10 doi: 10.1016/j.intimp.2019.04.057
|
| 3 |
Nanbao Zhong, Guangming Lv, Zhonghua Chen. High Dose-Volume SBRT Following TACE Improves Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma. Journal of Cancer Therapy 2016; 7(02): 152 doi: 10.4236/jct.2016.72016
|
| 4 |
Walifa Waqar, Sidra Asghar, Sobia Manzoor, Gianfranco D. Alpini. Platelets’ RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules. PLOS ONE 2021; 16(9): e0256739 doi: 10.1371/journal.pone.0256739
|
| 5 |
Faiza Essawy, Hoda Sadek, Sara Abdelaty, Manal Zahran, Bothaina Madkour, Karim Mashhour, Alaa Ismail, Dalia Amin. ABO blood group genotypes and risk of hepatocellular carcinoma in a cohort of Egyptian patients. Gene Reports 2020; 21: 100760 doi: 10.1016/j.genrep.2020.100760
|
| 6 |
Olayinka Fisayo Onifade, Oluseyi Adeboye Akinloye, Oluwatosin A. Dosumu, Abdul Lateef Aderemi Shotuyo. In silico and in vivo anti-angiogenic validation on ethanolic extract of Curcuma longa and curcumin compound in hepatocellular carcinoma through mitogen activated protein kinase expression in male and female wistar rats. Food and Chemical Toxicology 2023; 182: 114096 doi: 10.1016/j.fct.2023.114096
|
| 7 |
Jae Hwan Kwon, Sang Hoon Kim. YBX1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma via transcriptional regulation of PLRG1. Medical Oncology 2024; 41(11) doi: 10.1007/s12032-024-02516-0
|
| 8 |
Kerui Xu, Shinobu Watanabe-Galloway, Fedja A. Rochling, Jianjun Zhang, Paraskevi A. Farazi, Hongyan Peng, Hongmei Wang, Jiangtao Luo. Practice, Knowledge, and Barriers for Screening of Hepatocellular
Carcinoma Among High-Risk Chinese Patients. Annals of Global Health 2017; 83(2): 281 doi: 10.1016/j.aogh.2017.02.002
|
| 9 |
Chang-Cheng Zhao, Wen-Wei Yu, Ying-Jie Qi, Liang-Fei Xu, Zi-Ran Wang, Ya-Wen Qiang, Fan Ma, Xiao-Ling Ma. Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells. Anti-Cancer Drugs 2020; 31(3): 223 doi: 10.1097/CAD.0000000000000866
|
| 10 |
Jorge Simon, Alberto Ouro, Lolia Ala-Ibanibo, Natalia Presa, Teresa Cardoso Delgado, María Luz Martínez-Chantar. Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover. International Journal of Molecular Sciences 2019; 21(1): 40 doi: 10.3390/ijms21010040
|
| 11 |
Abdel-Rahman N. Zekri, Enas R. El-Sisi, Zeinab F. Abdallah, Alaa Ismail, Ahmed Barakat Barakat. Gene expression profiling of circulating CD133 + cells of hepatocellular carcinoma patients associated with HCV infection. Journal of the Egyptian National Cancer Institute 2017; 29(1): 19 doi: 10.1016/j.jnci.2016.12.002
|
| 12 |
Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo. Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma. Clinical and Molecular Hepatology 2023; 29(3): 721 doi: 10.3350/cmh.2023.0089
|
| 13 |
Chun-Ying Wu, Lee-Yuan Lin, Teng-Yu Lee, Yao-Chun Hsu, Chun-Chieh Yeh, Chiehfeng Chen, Yi-No Kang, Tsai-Wei Huang. Clinical guidelines for early hepatocellular carcinoma treatment options: a systematic review and bibliometric analysis. International Journal of Surgery 2024; 110(11): 7234 doi: 10.1097/JS9.0000000000001950
|
| 14 |
Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Ying He, Magdalena Swiatek‐de Lange, David Morgenstern, Henry Lik‐Yuen Chan. Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study. Hepatology Communications 2022; 6(4): 679 doi: 10.1002/hep4.1847
|
| 15 |
Dan‐Dan Zhou, Xiu‐fen Liu, Cheng‐wei Lu, Om Prakash Pant, Xiao‐dong Liu. Long non‐coding RNA PVT1: Emerging biomarker in digestive system cancer. Cell Proliferation 2017; 50(6) doi: 10.1111/cpr.12398
|
| 16 |
Wei Zou, Jun Cheng. MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting VHL. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820940425
|
| 17 |
Kayla Bastian, Emma Scott, David J. Elliott, Jennifer Munkley. FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer. International Journal of Molecular Sciences 2021; 22(1): 455 doi: 10.3390/ijms22010455
|
| 18 |
Mingjie Lu, Chen Wang, Yi Zhuo, Junjiu Gou, Yingfeng Li, Jingqi Li, Xue Dong. Preoperative prediction power of radiomics and non-radiomics methods based on MRI for early recurrence in hepatocellular carcinoma: a systemic review and meta-analysis. Abdominal Radiology 2024; 49(10): 3397 doi: 10.1007/s00261-024-04356-y
|
| 19 |
Kai Zheng, Chenghui Liao, Yan Li, Xinmin Fan, Long Fan, Hong Xu, Qiangrong Kang, Yong Zeng, Xuli Wu, Haiqiang Wu, Lizhong Liu, Xiaohua Xiao, Jian Zhang, Yifei Wang, Zhendan He. Gypenoside L, Isolated from Gynostemma pentaphyllum, Induces Cytoplasmic Vacuolation Death in Hepatocellular Carcinoma Cells through Reactive-Oxygen-Species-Mediated Unfolded Protein Response. Journal of Agricultural and Food Chemistry 2016; 64(8): 1702 doi: 10.1021/acs.jafc.5b05668
|
| 20 |
Amal A. Mohamed, Naglaa El-Toukhy, Doaa M. Ghaith, Ingy Badawy, Sara M. Abdo, Mahmoud Elkadeem, Mohamed N. Mahrous, Sherief Abd-Elsalam. Talin-1 Gene Expression as a Tumor Marker in Hepatocellular Carcinoma Patients: A Pilot Study. The Open Biomarkers Journal 2020; 10(1): 15 doi: 10.2174/1875318302010010015
|
| 21 |
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?. World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
|
| 22 |
Masataka Sakisaka, Miwa Haruta, Yoshihiro Komohara, Satoshi Umemoto, Keiko Matsumura, Tokunori Ikeda, Motohiro Takeya, Yukihiro Inomata, Yasuharu Nishimura, Satoru Senju. Therapy of primary and metastatic liver cancer by human iPS cell‐derived myeloid cells producing interferon‐β. Journal of Hepato-Biliary-Pancreatic Sciences 2017; 24(2): 109 doi: 10.1002/jhbp.422
|
| 23 |
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. American Society of Clinical Oncology Educational Book 2018; (38): 262 doi: 10.1200/EDBK_200939
|
| 24 |
Lei Cheng, Shuhang Gao, Xiaobo Song, Weijie Dong, Huimin Zhou, Lifen Zhao, Li Jia. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs. Oncotarget 2016; 7(38): 61199 doi: 10.18632/oncotarget.11284
|
| 25 |
Samantha L. Lipman, Mark L. Palmeri, Kathryn R. Nightingale. Large Field-of-View Shear Wave Imaging for Hepatocellular Carcinoma Screening. 2018 IEEE International Ultrasonics Symposium (IUS) 2018; : 1 doi: 10.1109/ULTSYM.2018.8579901
|
| 26 |
Haitao Jiang, Lianhe Zhao, Yunjie Chen, Liang Sun. A four‐long noncoding RNA signature predicts survival of hepatocellular carcinoma patients. Journal of Clinical Laboratory Analysis 2020; 34(9) doi: 10.1002/jcla.23377
|
| 27 |
Mingzhe Li, Fangfang Duan, Zhiqiang Pan, Xiaomei Liu, Wenli Lu, Chao Liang, Zhaoqin Fang, Peike Peng, Dongwei Jia. Astragalus Polysaccharide Promotes Doxorubicin-Induced Apoptosis by Reducing O-GlcNAcylation in Hepatocellular Carcinoma. Cells 2023; 12(6): 866 doi: 10.3390/cells12060866
|
| 28 |
Ge Gao, Xuke Luan. Diagnostic performance of clusterin in hepatocellular carcinoma: A meta-analysis. The International Journal of Biological Markers 2022; 37(4): 404 doi: 10.1177/03936155221101206
|
| 29 |
Ashwaq Alolyan, Kanan Alshammari, Mohammad Arabi, Ahmed Alshehri, Hamad Alsuhaibani, Fahad Ibnshamsah, Abdullah Alsharm, Mervat Mahrous, Adnan Al Zanbagi, Mazen Hassanain, Shouki Bazarbashi. Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia. Journal of Hepatocellular Carcinoma 2024; : 349 doi: 10.2147/JHC.S442842
|
| 30 |
B. Sumathy, Pankaj Dadheech, Monika Jain, Ankur Saxena, S. Hemalatha, Wenqi Liu, Stephen Jeswinde Nuagah, Waliullah Khan. A Liver Damage Prediction Using Partial Differential Segmentation with Improved Convolutional Neural Network. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/4055491
|
| 31 |
Guangfu Li, Dai Liu, Timothy K. Cooper, Eric T. Kimchi, Xiaoqiang Qi, Diego M. Avella, Ningfei Li, Qing X. Yang, Mark Kester, C. Bart Rountree, Jussuf T. Kaifi, David J. Cole, Don C. Rockey, Todd D. Schell, Kevin F. Staveley-O’Carroll. Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model. Journal of Hepatology 2017; 66(1): 75 doi: 10.1016/j.jhep.2016.07.044
|
| 32 |
Jiaxuan Xu, Yawen Cao, Xiangyan Wu, Yue Cheng, Xin Zhang. Neutrophil extracellular traps-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in hepatocellular carcinoma. Journal of Radiation Research and Applied Sciences 2023; 16(2): 100577 doi: 10.1016/j.jrras.2023.100577
|
| 33 |
Hong‐Xu Zhu, Wen‐Jie Lu, Wei‐Ping Zhu, Song Yu. Comprehensive analysis of N6‐methyladenosine‐related long non‐coding RNAs for prognosis prediction in liver hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2021; 35(12) doi: 10.1002/jcla.24071
|
| 34 |
Kosuke Iguchi, Ryota Sada, Shinji Matsumoto, Hirokazu Kimura, Yoh Zen, Masayuki Akita, Hidetoshi Gon, Takumi Fukumoto, Akira Kikuchi. DKK1‐CKAP4 signal axis promotes hepatocellular carcinoma aggressiveness. Cancer Science 2023; 114(5): 2063 doi: 10.1111/cas.15743
|
| 35 |
Neven A. Hagag, Yasser B. M. Ali, Ahmed A. Elsharawy, Roba M. Talaat. Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression. Journal of Gastrointestinal Cancer 2020; 51(1): 234 doi: 10.1007/s12029-019-00234-9
|
| 36 |
Sumit Roy, Vancha Harish, Sharfuddin Mohd, Sachin Kumar Singh. Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment. Advanced Therapeutics 2024; doi: 10.1002/adtp.202400126
|
| 37 |
Yifu Hou, Kai Chen, Rui Liao, Youzan Li, Hongji Yang, Jun Gong. LINC01419-mediated epigenetic silencing of ZIC1 promotes metastasis in hepatocellular carcinoma through the PI3K/Akt signaling pathway. Laboratory Investigation 2021; 101(5): 570 doi: 10.1038/s41374-021-00539-z
|
| 38 |
Xiu‐Fen Liu, Ji‐Long Hao, Tian Xie, Om Prakash Pant, Cheng‐Bo Lu, Cheng‐Wei Lu, Dan‐Dan Zhou. The BRAF activated non‐coding RNA: A pivotal long non‐coding RNA in human malignancies. Cell Proliferation 2018; 51(4) doi: 10.1111/cpr.12449
|
| 39 |
Alan Baronio Menegotto, Carla Diniz Lopes Becker, Silvio Cesar Cazella. Computer-aided diagnosis of hepatocellular carcinoma fusing imaging and structured health data. Health Information Science and Systems 2021; 9(1) doi: 10.1007/s13755-021-00151-x
|
| 40 |
Fahrettin Burak Demir, Turker Tuncer, Adnan Fatih Kocamaz, Fatih Ertam. A survival classification method for hepatocellular carcinoma patients with chaotic Darcy optimization method based feature selection. Medical Hypotheses 2020; 139: 109626 doi: 10.1016/j.mehy.2020.109626
|
| 41 |
Subbroto Saha, Yingfu Yin, Kyeongseok Kim, Gwang-Mo Yang, Ahmed Dayem, Hye Choi, Ssang-Goo Cho. Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences 2017; 18(5): 1048 doi: 10.3390/ijms18051048
|
| 42 |
Amani Ghousein, Nicola Mosca, Flora Cartier, Justine Charpentier, Jean‐William Dupuy, Anne‐Aurélie Raymond, Paulette Bioulac‐Sage, Christophe F. Grosset. miR‐4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation. Liver International 2020; 40(1): 240 doi: 10.1111/liv.14276
|
| 43 |
Jian Pu, Jianchu Wang, Wenchuan Li, Yuan Lu, Xianjian Wu, Xidai Long, Chunying Luo, Huamei Wei. hsa_circ_0000092 promotes hepatocellular carcinoma progression through up‐regulating HN1 expression by binding to microRNA‐338‐3p. Journal of Cellular and Molecular Medicine 2024; 28(6) doi: 10.1111/jcmm.15010
|
| 44 |
Ping Li, Hua Fan, Qiang He. Investigation of the clinical significance and prognostic value of microRNA-145 in human hepatocellular carcinoma. Medicine 2018; 97(51): e13715 doi: 10.1097/MD.0000000000013715
|
| 45 |
Yongping Zhou, Kuan Li, Tu Dai, Hong Wang, Zhiyuan Hua, Wuyang Bian, Hao Wang, Fangming Chen, Xiaoming Ai. Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A. Aging 2021; 13(12): 16267 doi: 10.18632/aging.203155
|
| 46 |
Naima Zayed Mohamed, Hanan Farouk Aly, Hatem Abdel moneim El-Mezayen, Hadeer E. El-Salamony. Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in rats. Toxicology Reports 2019; 6: 875 doi: 10.1016/j.toxrep.2019.08.007
|
| 47 |
Alex G. Raman, Craig Jones, Clifford R. Weiss. Machine Learning for Hepatocellular Carcinoma Segmentation at MRI:RadiologyIn Training. Radiology 2022; 304(3): 509 doi: 10.1148/radiol.212386
|
| 48 |
|
| 49 |
Woohyung Lee, Ho-Seong Han, Soyeon Ahn, Yoo-Seok Yoon, Jai Young Cho, YoungRok Choi. Correlation between Resection Margin and Disease Recurrence with a Restricted Cubic Spline Model in Patients with Resected Hepatocellular Carcinoma. Digestive Surgery 2018; 35(6): 520 doi: 10.1159/000485805
|
| 50 |
Alan Baronio Menegotto, Carla Diniz Lopes Becker, Silvio Cesar Cazella. Ambient Intelligence – Software and Applications –,10th International Symposium on Ambient Intelligence. Advances in Intelligent Systems and Computing 2020; 1006: 3 doi: 10.1007/978-3-030-24097-4_1
|
| 51 |
Aixian Zheng, Xiaolong Zhang, Ju Gao, Xiaolong Liu, Jingfeng Liu. Peroxidase-like catalytic activity of copper ions and its application for highly sensitive detection of glypican-3. Analytica Chimica Acta 2016; 941: 87 doi: 10.1016/j.aca.2016.08.036
|
| 52 |
Heba Sedrak, Noaman El-Garem, Mervat Naguib, Heba El-Zawahry, Mohamed Esmat, Lila Rashed. Vascular endothelial growth factor before and after locoregional treatment and its relation to treatment response in hepatocelluar carcinoma patients. Asian Pacific Journal of Tropical Biomedicine 2015; 5(12): 1005 doi: 10.1016/j.apjtb.2015.09.006
|
| 53 |
David Hao, Vwaire Orhurhu. Interventional Management of Chronic Visceral Pain Syndromes. 2021; : 85 doi: 10.1016/B978-0-323-75775-1.00014-3
|
| 54 |
Feng Chen, Huihui Wang, Jiayu Zhu, Rui Zhao, Peng Xue, Qiang Zhang, M Bud Nelson, Weidong Qu, Bo Feng, Jingbo Pi. Camptothecin suppresses NRF2–ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs. British Journal of Cancer 2017; 117(10): 1495 doi: 10.1038/bjc.2017.317
|
| 55 |
Dipak D. Meshram, Claire V.S. Pike, Peter J. Coussons. Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapy. European Journal of Pharmacology 2017; 815: 332 doi: 10.1016/j.ejphar.2017.09.035
|
| 56 |
Jia-Cheng Tang, Yi-Li Feng, Tao Guo, An-Yong Xie, Xiu-Jun Cai. Circulating tumor DNA in hepatocellular carcinoma: trends and challenges. Cell & Bioscience 2016; 6(1) doi: 10.1186/s13578-016-0100-z
|
| 57 |
Badrinathan Sridharan, Naveen Devarajan, Rupal Jobanputra, Genekehal Siddaramana Gowd, Ida Mulayirikkal Anna, Anusha Ashokan, Shantikumar Nair, Manzoor Koyakutty. nCP:Fe Nanocontrast Agent for Magnetic Resonance Imaging-Based Early Detection of Liver Cirrhosis and Hepatocellular Carcinoma. ACS Applied Bio Materials 2021; 4(4): 3398 doi: 10.1021/acsabm.1c00001
|
| 58 |
Yuan Li, Zhong Li, Yunhao Jia, Bo Ding, Jinsong Yu. In Vitro Anti-hepatoma Activities of Notoginsenoside R1 Through Downregulation of Tumor Promoter miR-21. Digestive Diseases and Sciences 2020; 65(5): 1364 doi: 10.1007/s10620-019-05856-4
|
| 59 |
Qiang Gao, Qiang Zeng, Zhijie Wang, Chengcheng Li, Yu Xu, Peng Cui, Xin Zhu, Huafei Lu, Guoqiang Wang, Shangli Cai, Jie Wang, Jia Fan. Circulating cell-free DNA for cancer early detection. The Innovation 2022; 3(4): 100259 doi: 10.1016/j.xinn.2022.100259
|
| 60 |
Nikita Sehgal, Ruchi Jakhmola Mani, Nitu Dogra, Deepshikha Pande Katare. Biosensor Based Advanced Cancer Diagnostics. 2022; : 97 doi: 10.1016/B978-0-12-823424-2.00009-0
|
| 61 |
金鹏 王. Research Status of LncRNA in Tumor Metastasis and Invasion. Advances in Clinical Medicine 2023; 13(07): 12136 doi: 10.12677/ACM.2023.1371701
|
| 62 |
Pammi Raj Gupta, Pradyumna Ghosh, Jahar Sarkar. Effects of probe parameters on radio-frequency ablation of localized liver cancer using a personalized patient treatment planning. Thermal Science and Engineering Progress 2023; 46: 102236 doi: 10.1016/j.tsep.2023.102236
|
| 63 |
Salman Wahib Srayaldeen, Mohamed Ahmed Mohamed Elkhalifa. Cancer Care in the United Arab Emirates. 2024; : 491 doi: 10.1007/978-981-99-6794-0_30
|
| 64 |
Wei Chen, Junnan Ru, Tong Wu, Da Man, Jingbang Wu, Lijuan Wu, Yujing Sun, Hanxi Yu, Min Li, Gangwei Zhang, Xingxin Zhu, Rongliang Tong, Heng Xiao, Yanhua Li, Beng Yang. MiR-652-3p promotes malignancy and metastasis of cancer cells via inhibiting TNRC6A in hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2023; 640: 1 doi: 10.1016/j.bbrc.2022.11.100
|
| 65 |
Jing Li, Zhi-Ye Liu, Hai-Bo Yu, Qing Xue, Xiu-Sheng Qu. Effects of oxymatrine on the proliferation of human liver cancer Bel-7404 cells. Medicine 2020; 99(23): e20181 doi: 10.1097/MD.0000000000020181
|
| 66 |
Kun Liu, Yuening Zhang, Chengdong Zhang, Qinle Zhang, Jiatong Li, Feifan Xiao, Yingfang Li, Ruoheng Zhang, Dongwei Dou, Jiezhen Liang, Jian Qin, Zhidi Lin, Dong Zhao, Min Jiang, Zhenxin Liang, Jie Su, Vanaparthy Pranay Gupta, Min He, Xiaoli Yang. Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma. Oncotarget 2016; 7(35): 56798 doi: 10.18632/oncotarget.10792
|
| 67 |
Doris Schneller, Peter Angel. Hepatocellular Carcinoma. 2019; : 1 doi: 10.15586/hepatocellularcarcinoma.2019.ch1
|
| 68 |
Xiongqun Peng, Huixiang Yang, Lijian Tao, Jingni Xiao, Ya Zeng, Yueming Shen, Xueke Yu, Fei Zhu, Jiao Qin. Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer. PeerJ 2023; 11: e16060 doi: 10.7717/peerj.16060
|
| 69 |
Chuqian Zheng, Xiuxia Liu, Leifeng Chen, Zheng Xu, Jianghua Shao. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 2017; 8(35): 59638 doi: 10.18632/oncotarget.19559
|
| 70 |
Zhiyi Han, Wenxing Feng, Rui Hu, Qinyu Ge, Wenfeng Ma, Wei Zhang, Shaomin Xu, Bolin Zhan, Lai Zhang, Xinfeng Sun, Xiaozhou Zhou. RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-96952-x
|
| 71 |
M Omar, K Farid, T Emran, F El-Taweel, A Tabll, M Omran. HCC-Mark: a simple non-invasive model based on routine parameters for predicting hepatitis C virus related hepatocellular carcinoma. British Journal of Biomedical Science 2021; 78(2): 72 doi: 10.1080/09674845.2020.1832371
|
| 72 |
Martin Reinhardt, Philipp Brandmaier, Daniel Seider, Marina Kolesnik, Sjoerd Jenniskens, Roberto Blanco Sequeiros, Martin Eibisberger, Philip Voglreiter, Ronan Flanagan, Panchatcharam Mariappan, Harald Busse, Michael Moche. A prospective development study of software-guided radio-frequency ablation of primary and secondary liver tumors: Clinical intervention modelling, planning and proof for ablation cancer treatment (ClinicIMPPACT). Contemporary Clinical Trials Communications 2017; 8: 25 doi: 10.1016/j.conctc.2017.08.004
|
| 73 |
Sathish Kumar Mungamuri, Kotikalapudi Nagasuryaprasad. Epigenetics and Metabolomics. 2021; : 279 doi: 10.1016/B978-0-323-85652-2.00008-7
|
| 74 |
Agnieszka Kopystecka, Rafał Patryn, Magdalena Leśniewska, Julia Budzyńska, Ilona Kozioł. The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review. International Journal of Molecular Sciences 2023; 24(11): 9342 doi: 10.3390/ijms24119342
|
| 75 |
Hao Xing, Haibo Qiu, Xuemei Ding, Jun Han, Zhenli Li, Han Wu, Cunling Yan, Huijun Li, Ruilin Han, Han Zhang, Chao Li, Mingda Wang, Mengchao Wu, Feng Shen, Yijie Zheng, Tian Yang. Clinical Performance of α-L-Fucosidase for Early Detection of Hepatocellular Carcinoma. Biomarkers in Medicine 2019; 13(7): 545 doi: 10.2217/bmm-2018-0414
|
| 76 |
Shannon Weigum, Elizabeth McIvor, Christopher Munoz, Richard Feng, Travis Cantu, Kyle Walsh, Tania Betancourt. Targeted therapy of hepatocellular carcinoma with aptamer-functionalized biodegradable nanoparticles. Journal of Nanoparticle Research 2016; 18(11) doi: 10.1007/s11051-016-3633-5
|
| 77 |
Mei-Xi Wang, Dong Chen, Yuan-Yuan Zhao, Bo Yang, Ji-Pin Jiang, Fan-Jun Zeng, Lai Wei, Zhi-Shui Chen. Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation. Hepatobiliary & Pancreatic Diseases International 2020; 19(4): 378 doi: 10.1016/j.hbpd.2020.06.008
|
| 78 |
Soumen Barman, Ishita Bardhan, Jyotirmayee Padhan, Babu Sudhamalla. Integrated virtual screening and MD simulation approaches toward discovering potential inhibitors for targeting BRPF1 bromodomain in hepatocellular carcinoma. Journal of Molecular Graphics and Modelling 2024; 126: 108642 doi: 10.1016/j.jmgm.2023.108642
|
| 79 |
T. C. Saat, S. van den Engel, W. Bijman-Lachger, S. S. Korevaar, M. J. Hoogduijn, J. N. M. IJzermans, R. W. F. de Bruin, Benedetta Bussolati. Fate and Effect of Intravenously Infused Mesenchymal Stem Cells in a Mouse Model of Hepatic Ischemia Reperfusion Injury and Resection. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/5761487
|
| 80 |
Suayib Yalcin, Sahin Lacin, Ahmed Kaseb, Bora Peynircioğlu, Murat Cantasdemir, Barbaros Çil, Pervin Hurmuz, Ahmet Doğrul, Murat Bozkurt, Hüseyin Abali, Okan Akhan, Halis Şimşek, Berksoy Sahin, Faruk Aykan, İdris Yücel, Gürkan Tellioğlu, Fatih Selçukbiricik, Philip Philip. A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements. Journal of Hepatocellular Carcinoma 2024; : 953 doi: 10.2147/JHC.S449540
|
| 81 |
Libby Sadler, Hayley Jones, Penny Whiting, Morwenna Rogers, Kelsey Watt, Matthew Cramp, Stephen Ryder, Ken Stein, Nicky Welton, Felicity Oppe, John Bell, Gabriel Rogers. Diagnostic accuracy of serological and imaging tests used in surveillance for hepatocellular carcinoma in adults with cirrhosis: a systematic review protocol. NIHR Open Research 2024; 3: 23 doi: 10.3310/nihropenres.13409.2
|
| 82 |
Benjamin Wei Rong Tay, Daniel Q. Huang, Muthiah Mark, Neo Wee Thong, Lee Guan Huei, Lim Seng Gee, Low How Cheng, Lee Yin Mei, Prem Thurairajah, Lim Jia Chen, Cheng Han Ng, Wen Hui Lim, Darren Jun Hao Tan, Da Costa Maureen, Kow Wei Chieh Alfred, Iyer Shridar Ganpathi, Tan Poh Seng, Dan Yock Young. Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation. Biomedicines 2022; 10(10): 2361 doi: 10.3390/biomedicines10102361
|
| 83 |
CHENG-YUN DOU, CHUANG-JIE CAO, ZHUO WANG, RU-HUA ZHANG, LEI-LEI HUANG, JIA-YAN LIAN, WEN-LIN XIE, LIAN-TANG WANG. EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity. Oncology Reports 2016; 35(6): 3489 doi: 10.3892/or.2016.4733
|
| 84 |
Sean L. Zheng, Vincent S. Yip, Federica Pedica, Andreas Prachalias, Alberto Quaglia. Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: a case report and review of the literature. Diagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0439-1
|
| 85 |
Jiahui Liu, Ling Huang, Yi Zhu, Yongyin He, Weiyun Zhang, Ting Lei, Junfeng Xuan, Bin Xiao, Linhai Li, Quan Zhou, Zhaohui Sun. Exploring the Expression and Prognostic Value of the TCP1 Ring Complex in Hepatocellular Carcinoma and Overexpressing Its Subunit 5 Promotes HCC Tumorigenesis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.739660
|
| 86 |
Arnetta N.L. Lalisang, Nathaniel J. Zacharia, Indah Jamtani, Vania M.G. Marbun, Wifanto Saditya Jeo, Toar Jean Maurice Lalisang. Pedunculated hepatocellular carcinoma masquerading as a giant GIST: A case report. International Journal of Surgery Case Reports 2023; 105: 108102 doi: 10.1016/j.ijscr.2023.108102
|
| 87 |
Peike Peng, Dongwei Jia, Linna Cao, Wenli Lu, Xiaomei Liu, Chao Liang, Zhiqiang Pan, Zhaoqin Fang. Akebia saponin E, as a novel PIKfyve inhibitor, induces lysosome-associated cytoplasmic vacuolation to inhibit proliferation of hepatocellular carcinoma cells. Journal of Ethnopharmacology 2021; 266: 113446 doi: 10.1016/j.jep.2020.113446
|
| 88 |
Siqi Li, Huiyan Jiang, Yu-dong Yao, Wenbo Pang, Qingjiao Sun, Li Kuang. Structure convolutional extreme learning machine and case-based shape template for HCC nucleus segmentation. Neurocomputing 2018; 312: 9 doi: 10.1016/j.neucom.2018.05.013
|
| 89 |
Vo Hoang Xuan Dat, Bui Thi Huyen Nhung, Nguyen Ngoc Bao Chau, Pham Hung Cuong, Vo Duc Hieu, Nguyen Thi Minh Linh, Nguyen Bao Quoc. Identification of potential microRNA groups for the diagnosis of hepatocellular carcinoma (HCC) using microarray datasets and bioinformatics tools. Heliyon 2022; 8(2): e08987 doi: 10.1016/j.heliyon.2022.e08987
|
| 90 |
J. Sastre, R. Díaz-Beveridge, J. García-Foncillas, R. Guardeño, C. López, R. Pazo, N. Rodriguez-Salas, M. Salgado, A. Salud, J. Feliu. Clinical guideline SEOM: hepatocellular carcinoma. Clinical and Translational Oncology 2015; 17(12): 988 doi: 10.1007/s12094-015-1451-3
|
| 91 |
Joshua P Kronenfeld, Neha Goel. An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; : 1209 doi: 10.2147/JHC.S284430
|
| 92 |
Nuozhou Wang, Shanshan Wang, Ming-Yue Li, Bao-guang Hu, Li-ping Liu, Sheng-li Yang, Shucai Yang, Zhongqin Gong, Paul B. S. Lai, George G. Chen. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies. Therapeutic Advances in Medical Oncology 2018; 10 doi: 10.1177/1758835918816287
|
| 93 |
Mai Mohyeldeen, Safinaz Ibrahim, Olfat Shaker, Hebatullah Helmy. Serum expression and diagnostic potential of long non-coding RNAs NEAT1 and TUG1 in viral hepatitis C and viral hepatitis C-associated hepatocellular carcinoma. Clinical Biochemistry 2020; 84: 38 doi: 10.1016/j.clinbiochem.2020.06.005
|
| 94 |
Kabir Mody, Sean P. Cleary. A Review of Circulating Tumor DNA in Hepatobiliary Malignancies. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00212
|
| 95 |
Benjamin Koh, Pojsakorn Danpanichkul, Meng Wang, Darren Jun Hao Tan, Cheng Han Ng. Application of artificial intelligence in the diagnosis of hepatocellular carcinoma. eGastroenterology 2023; 1(2): e100002 doi: 10.1136/egastro-2023-100002
|
| 96 |
Liang Ma, Lei Peng, Sheng Fang, Bangguo He, Zi Liu. Celastrol downregulates E2F1 to induce growth inhibitory effects in hepatocellular carcinoma HepG2 cells. Oncology Reports 2017; 38(5): 2951 doi: 10.3892/or.2017.5971
|
| 97 |
Mengxuan Lu, Xia Kong, Huaigao Wang, Guoliang Huang, Caiguo Ye, Zhiwei He. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Oncotarget 2017; 8(5): 8775 doi: 10.18632/oncotarget.14452
|
| 98 |
Feng Wang, Jun Wang, Linlin Ju, Lin Chen, Weihua Cai, Jialin Yang. Diagnostic and prognostic potential of serum miR-132/212 cluster in patients with hepatocellular carcinoma. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2018; 55(5): 576 doi: 10.1177/0004563218755815
|
| 99 |
Nikolaos Galanakis, Elias Kehagias, Nikolas Matthaiou, Dimitrios Samonakis, Dimitrios Tsetis. Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review. Hepatic Oncology 2018; 5(2) doi: 10.2217/hep-2018-0001
|
| 100 |
Qi-Fan Qin, Jie Weng, Gan-Xin Xu, Chun-Ming Chen, Chang-Ku Jia. Combination of serum tumor markers dickkopf-1, DCP and AFP for the diagnosis of primary hepatocellular carcinoma. Asian Pacific Journal of Tropical Medicine 2017; 10(4): 409 doi: 10.1016/j.apjtm.2017.03.016
|
| 101 |
Hyun Joon An, Woo Young Shin, Keon-Young Lee, Seung-Ik Ahn. A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma. Korean Journal of Hepato-Biliary-Pancreatic Surgery 2015; 19(3): 89 doi: 10.14701/kjhbps.2015.19.3.89
|
| 102 |
Pei Hu, Changzheng Ke, Xingrong Guo, Pan Ren, Yaoyao Tong, Sen Luo, Yulin He, Zhiqiang Wei, Bin Cheng, Ruiming Li, Jie Luo, Zhongji Meng. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma. Digestive and Liver Disease 2019; 51(1): 120 doi: 10.1016/j.dld.2018.06.012
|
| 103 |
Dongling Zhu, Yushuang Qin, Jingjing Wang, Liwen Zhang, Sijuan Zou, Xiaohua Zhu, Lei Zhu. Novel Glypican-3-Binding Peptide for in Vivo Hepatocellular Carcinoma Fluorescent Imaging. Bioconjugate Chemistry 2016; 27(3): 831 doi: 10.1021/acs.bioconjchem.6b00030
|
| 104 |
Fan Yang, Jing Zhao, Chunwei Liu, Yiran Mao, Jie Mu, Xi Wei, Jinyan Jia, Sheng Zhang, Xiaojie Xin, Jian Tan. Superb microvascular imaging technique in depicting vascularity in focal liver lesions: more hypervascular supply patterns were depicted in hepatocellular carcinoma. Cancer Imaging 2019; 19(1) doi: 10.1186/s40644-019-0277-6
|
| 105 |
Teerha Piratvisuth, Jinlin Hou, Tawesak Tanwandee, Thomas Berg, Arndt Vogel, Jörg Trojan, Enrico N. De Toni, Masatoshi Kudo, Anja Eiblmaier, Hanns-Georg Klein, Johannes Kolja Hegel, Kairat Madin, Konstantin Kroeniger, Ashish Sharma, Henry L.Y. Chan. Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies. Hepatology Communications 2023; 7(11) doi: 10.1097/HC9.0000000000000317
|
| 106 |
Rui Zhang, Peng Lin, Hong Yang, Yun He, Yi-Wu Dang, Zhen-Bo Feng, Gang Chen. Clinical role and biological function of CDK5 in hepatocellular carcinoma: A study based on immunohistochemistry, RNA-seq andin vitroinvestigation. Oncotarget 2017; 8(65): 108333 doi: 10.18632/oncotarget.22659
|
| 107 |
Harrison Dai, Harrison Klause, Richard M. Conran. Educational Case: Hepatocellular carcinoma. Academic Pathology 2024; 11(1): 100108 doi: 10.1016/j.acpath.2024.100108
|
| 108 |
Jun‐Cheng Guo, Yi‐Jun Yang, Jian‐Quan Zhang, Min Guo, Li Xiang, Shu‐Feng Yu, Huang Ping, Liu Zhuo. microRNA‐448 inhibits stemness maintenance and self‐renewal of hepatocellular carcinoma stem cells through the MAGEA6‐mediated AMPK signaling pathway. Journal of Cellular Physiology 2019; 234(12): 23461 doi: 10.1002/jcp.28915
|
| 109 |
Yanting Shen, Lu Bu, Rui Li, Zhenzhu Chen, Fei Tian, Na Lu, Qinyu Ge, Yunfei Bai, Zuhong Lu. Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq. Oncotarget 2017; 8(17): 27976 doi: 10.18632/oncotarget.15855
|
| 110 |
Georg J. Wengert, Pascal A.T. Baltzer, Hubert Bickel, Patrick Thurner, Julia Breitenseher, Mathias Lazar, Matthias Pones, Markus Peck-Radosavljevic, Florian Hucke, Ahmed Ba-Ssalamah. Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR Imaging. Academic Radiology 2017; 24(12): 1491 doi: 10.1016/j.acra.2017.06.005
|
| 111 |
N. Sasirekha, I. Poonguzhali, Himanshu Shekhar, S. Vimalnath. Liver tumour detection and classification using partial differential technique algorithm with enhanced convolutional classifier. Journal of Intelligent & Fuzzy Systems 2023; 45(5): 7939 doi: 10.3233/JIFS-232218
|
| 112 |
Libby Sadler, Hayley Jones, Penny Whiting, Morwenna Rogers, Kelsey Watt, Matthew Cramp, Stephen Ryder, Ken Stein, Nicky Welton, Felicity Oppe, John Bell, Gabriel Rogers. Diagnostic accuracy of serological and imaging tests used in surveillance for hepatocellular carcinoma in adults with cirrhosis: a systematic review protocol. NIHR Open Research 2023; 3: 23 doi: 10.3310/nihropenres.13409.1
|
| 113 |
Ya Li, Zhenwei Song, Qiuju Han, Huajun Zhao, Zhaoyi Pan, Zhengyang Lei, Jian Zhang. Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis. Molecular Oncology 2022; 16(15): 2861 doi: 10.1002/1878-0261.13263
|
| 114 |
Takeshi Harada, Shinji Matsumoto, Suguru Hirota, Hirokazu Kimura, Shinsuke Fujii, Yuuya Kasahara, Hidetoshi Gon, Toshihiko Yoshida, Tomoo Itoh, Naotsugu Haraguchi, Tsunekazu Mizushima, Takehiro Noda, Hidetoshi Eguchi, Satoshi Nojima, Eiichi Morii, Takumi Fukumoto, Satoshi Obika, Akira Kikuchi. Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth. Molecular Cancer Therapeutics 2019; 18(3): 602 doi: 10.1158/1535-7163.MCT-18-0824
|
| 115 |
Farzaneh Abam, Saeid Ghorbian. The dual role of LncRNAs in hepatocellular carcinoma: Friend and foe. Gastroenterology & Endoscopy 2024; 2(4): 186 doi: 10.1016/j.gande.2024.06.001
|
| 116 |
Rui Cao, Hongguang Liu , Zhen Cheng. Radiolabeled Peptide Probes for Liver Cancer Imaging. Current Medicinal Chemistry 2020; 27(41): 6968 doi: 10.2174/0929867327666200320153837
|
| 117 |
Moritz T. Winkelmann, Rami Archid, Georg Gohla, Gerald Hefferman, Jens Kübler, Jakob Weiss, Stephan Clasen, Konstantin Nikolaou, Silvio Nadalin, Rüdiger Hoffmann. MRI-guided percutaneous thermoablation in combination with hepatic resection as parenchyma-sparing approach in patients with primary and secondary hepatic malignancies: single center long-term experience. Cancer Imaging 2020; 20(1) doi: 10.1186/s40644-020-00316-z
|
| 118 |
Yuchuan Zhong, Yan Li, Tao Song, Dapeng Zhang. MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and PTEN to regulate the proliferation of hepatocellular carcinoma cells. Physiological Genomics 2019; 51(10): 500 doi: 10.1152/physiolgenomics.00019.2019
|
| 119 |
Li-Yue Sun, Qing Ouyang, Wen-Jian Cen, Fang Wang, Wen-Ting Tang, Jian-Yong Shao. A Model Based on Artificial Intelligence Algorithm for Monitoring Recurrence of HCC after Hepatectomy. The American Surgeon™ 2023; 89(5): 1468 doi: 10.1177/00031348211063549
|
| 120 |
G. Naveen Sundar, Stalin Selvaraj, D. Narmadha, K. Martin Sagayam, A. Amir Anton Jone, Ayman A. Aly, Dac-Nhuong Le. An Intelligent Prediction Model for Target Protein Identification in Hepatic Carcinoma Using Novel Graph Theory and ANN Model. Computer Modeling in Engineering & Sciences 2022; 133(1): 31 doi: 10.32604/cmes.2022.019914
|
| 121 |
Xin Jiang, Yushuang Xu, Di Chen, Mengmeng Wang, Mengjun Qiu, Lina Xiong, Li Zhang, Honglu Yu, Zhifan Xiong. A Novel Angiogenesis-Related Prognostic Signature Associated with the Hepatocellular Carcinoma Immune Microenvironment and Survival Outcome. International Journal of General Medicine 2022; : 311 doi: 10.2147/IJGM.S349210
|
| 122 |
Zi Yin, Tingting Ma, Ye Lin, Xin Lu, Chuanzhao Zhang, Sheng Chen, Zhixiang Jian. Retracted: IL‐6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma. Journal of Cellular Biochemistry 2018; 119(11): 9419 doi: 10.1002/jcb.27259
|
| 123 |
Sang Eun Ha, Seong Min Kim, Ho Jeong Lee, Preethi Vetrivel, Venu Venkatarame Gowda Saralamma, Jeong Doo Heo, Eun Hee Kim, Sang Joon Lee, Gon Sup Kim. Scutellarein Induces Fas-Mediated Extrinsic Apoptosis and G2/M Cell Cycle Arrest in Hep3B Hepatocellular Carcinoma Cells. Nutrients 2019; 11(2): 263 doi: 10.3390/nu11020263
|
| 124 |
Yang Zhang, Yan Yang, Yi Zhang, Zhisu Liu. lncRNA ST8SIA6‑AS1 facilitates proliferation and invasion in liver cancer by regulating miR‑142‑3p. Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10783
|
| 125 |
Jian Ruan, Haiyan Zheng, Xiaodong Rong, Xiaomin Rong, Junyi Zhang, Weijia Fang, Peng Zhao, Rongcheng Luo. Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients. Molecular Cancer 2016; 15(1) doi: 10.1186/s12943-016-0503-9
|
| 126 |
Asahiro Morishita, Tsutomu Masaki. MicroRNAs as possible biomarkers for hepatocellular carcinoma. Hepatology Research 2018; 48(7): 499 doi: 10.1111/hepr.13078
|
| 127 |
Toshiro Masuda, Toru Beppu, Hirohisa Okabe, Hidetoshi Nitta, Katsunori Imai, Hiromitsu Hayashi, Akira Chikamoto, Kenichiro Yamamoto, Satoshi Ikeshima, Masafumi Kuramoto, Shinya Shimada, Hideo Baba. Predictive factors of pathological vascular invasion in hepatocellular carcinoma within 3 cm and three nodules without radiological vascular invasion. Hepatology Research 2016; 46(10): 985 doi: 10.1111/hepr.12637
|
| 128 |
Lin-Hong Mao, Si-Yuan Chen, Xiao-Qin Li, Feng Xu, Jing Lei, Qing-Liang Wang, Li-Yang Luo, Hai-Yan Cao, Xin Ge, Tao Ran, Xue Li, Min Zou, Zhi-Hang Zhou, Xiao-Ling Wu, Song He. LncRNA-LALR1 upregulates small nucleolar RNA SNORD72 to promote growth and invasion of hepatocellular carcinoma. Aging 2020; 12(5): 4527 doi: 10.18632/aging.102907
|
| 129 |
Evgenii A. Zherebtsov, Elena V. Potapova, Andrian V. Mamoshin, Valery V. Shupletsov, Ksenia Y. Kandurova, Viktor V. Dremin, Andrey Y. Abramov, Andrey V. Dunaev. Fluorescence lifetime needle optical biopsy discriminates hepatocellular carcinoma. Biomedical Optics Express 2022; 13(2): 633 doi: 10.1364/BOE.447687
|
| 130 |
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Michela Visani, Giorgia Acquaviva, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Luca Di Tommaso, Arrigo Bondi, Sergio Sabbatani, Andrea Domanico, Carlo Fabbri, Paolo Leandri, Annalisa Pession, Elio Jovine, Dario de Biase. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. World Journal of Gastroenterology 2016; 22(15): 3907-3936 doi: 10.3748/wjg.v22.i15.3907
|
| 131 |
Jinyu Yu, Junqing Han, Jian Zhang, Guanzhen Li, Hui Liu, Xianping Cui, Yantian Xu, Tao Li, Juan Liu, Chuanxi Wang. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis. Medicine 2016; 95(31): e4436 doi: 10.1097/MD.0000000000004436
|
| 132 |
Farid M. Sroor, Wahid M. Basyouni, Hanan F. Aly, Eman A. Younis, Karima F. Mahrous, Ahmed A. Haroun. Biochemical and histopathological studies of sulfonylurea derivative as a new chemotherapeutic agent against liver cancer in free- and nano-coated forms. Applied Biological Chemistry 2022; 65(1) doi: 10.1186/s13765-022-00737-3
|
| 133 |
Shahira Amin Zayed, Nariman M. Zahran, Mervat Mamdooh Khorshied, Ashraf Omar Abdel‐Aziz, Ola Mahmoud, Shereif Ahmed Morsy, Hend Ibrahim Shousha, Tamer Mahmoud Elbaz, Mohamed Mahmoud Nabeel, Amira Ramadan Korany Harb. Genetic variations in death receptor domain 4 gene and the susceptibility to hepatitis C related hepatocellular carcinoma. Journal of Medical Virology 2019; 91(8): 1537 doi: 10.1002/jmv.25476
|
| 134 |
Yong Xie, Huan Tian, Bin Xiang, Yongjin Zhang, Jian Liu, Zhuoyan Cai, Hua Xiang. Transarterial chemoembolization plus sorafenib versus sorafenib for intermediate–advanced hepatocellular carcinoma. Medicine 2021; 100(33): e26958 doi: 10.1097/MD.0000000000026958
|
| 135 |
Haoran Xu, Yongjia Tang, Yue Zhao, Fang Wang, Xin Gao, Dawei Deng, Yueqing Gu. SPECT Imaging of Hepatocellular Carcinoma Detection by the GPC3 Receptor. Molecular Pharmaceutics 2021; 18(5): 2082 doi: 10.1021/acs.molpharmaceut.1c00060
|
| 136 |
Yehya Slim, Maija Rikmane, Sergejs Grigorjevs, Jevgenijs Stepanovs, Biruta Mamaja. Post Operative Pain Management for Open Inguinal Hernia Repair under Ultrasound Guidance with two Different Regional Analgesia Techniques: Transversus Abdominis Plane Block VS Ilioinguinal / Iliohypogastric Nerves Block. Acta Chirurgica Latviensis 2014; 14(2): 18 doi: 10.1515/chilat-2015-0004
|
| 137 |
Zihao Fan, Hao Pan, Na Qu, Xin Wang, Lianrui Cao, Lijiang Chen, Mingxia Liu. LncRNA taurine upregulated gene 1 in liver disease. Clinica Chimica Acta 2024; 560: 119752 doi: 10.1016/j.cca.2024.119752
|
| 138 |
Huiqin Jiang, Wenjing Yang, Anli Jin, Hao Wang, Tong Li, Jingrong Xian, Wei Chen, Ling Ding, Beili Wang, Wei Guo. Liquid Biopsy for Early Diagnosis of Hepatocellular Carcinoma: Current
State and Future Perspectives. Current Chinese Science 2023; 3(6): 420 doi: 10.2174/2210298103666230410105139
|
| 139 |
Gurjot Singh, Eric M Yoshida, Sahaj Rathi, Vladimir Marquez, Peter Kim, Siegfried R Erb, Baljinder S Salh. Biomarkers for hepatocellular cancer. World Journal of Hepatology 2020; 12(9): 558-573 doi: 10.4254/wjh.v12.i9.558
|
| 140 |
Swathi Mohankumar, Tushar Patel. Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer. Briefings in Functional Genomics 2016; 15(3): 249 doi: 10.1093/bfgp/elv058
|
| 141 |
Lanxin Mu, Luhe Qi, Haitao Long, Jing Huang, Zibiao Zhong, Xiaowen Shi, Chaoji Chen, Qifa Ye. Photothermal Fibrous Chitosan/Polydopamine Sponge for Intraoperative Hemostasis and Prevention of Tumor Recurrence in Hepatocellular Carcinoma Resection. Advanced Science 2024; 11(3) doi: 10.1002/advs.202304053
|
| 142 |
Ashraf Omar, Ahmed Kaseb, Tamer Elbaz, Mohamed El-Kassas, Amr El Fouly, Abdel Fatah Hanno, Ahmed El Dorry, Ahmed Hosni, Amr Helmy, Amr S Saad, Ashwaq Alolayan, Basem Eysa, Emad Hamada, Hamdy Azim, Hany Khattab, Hesham Elghazaly, Hesham Tawfik, Hisham Ayoub, Hussein Khaled, Ibtessam Saadeldin, Imam Waked, Eman Barakat, Mahmoud El Meteini, Mohamed Hamed Shaaban, Mohamed EzzElarab, Mohamed Fathy, Mohamed Shaker, Mohamed Sobhi, Mohamed Shaker, Mohamed ElGharib, Mohammed Abdullah, Mohesn Mokhtar, Mostafa Elshazli, Omar Heikal, Osama Hetta, Reda ElWakil, Sameh Abdel Wahab, Samir Eid, Yousri Rostom. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1547 doi: 10.2147/JHC.S404424
|
| 143 |
So Young Yoo, Narayanasamy Badrinath, Hyun Young Woo, Jeong Heo. Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/5198798
|
| 144 |
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
|
| 145 |
Zuxiong Tang, Jun He, Jiayue Zou, Shufei Yu, Xiaoming Sun, Lei Qin. Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC. PeerJ 2021; 9: e11200 doi: 10.7717/peerj.11200
|
| 146 |
Rafael Miret, Amir Riaz, Sikandar Khan, Asad Ur Rahman. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 275 doi: 10.1016/B978-0-323-99283-1.00010-0
|
| 147 |
Neha Merchant, Sujatha Peela, Afroz Alam, Ganji Purnachandra Nagaraju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 161 doi: 10.1016/B978-0-323-99283-1.00025-2
|
| 148 |
Rodolfo Sacco, Michela Antonucci, Giampaolo Bresci, Ambra Corti, Luca Giacomelli, Valeria Mismas, Maurizio Rainieri, Antonio Romano, Roberto Eggenhoffner, Emanuele Tumino, Giuseppe Cabibbo. Curative therapies for hepatocellular carcinoma: an update and perspectives. Expert Review of Anticancer Therapy 2016; 16(2): 169 doi: 10.1586/14737140.2016.1123625
|
| 149 |
Yinuo Li, Shosei Shimizu, Masashi Mizumoto, Takashi Iizumi, Haruko Numajiri, Hirokazu Makishima, Gong Li, Hideyuki Sakurai. Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation. Cureus 2022; doi: 10.7759/cureus.25744
|
| 150 |
RUNZHE CHEN, ZENGXIN GAO, XIAOTAO WU, JOS L. CAMPBELL, PEI ZHANG, BAOAN CHEN. Hepatocellular carcinoma presenting as thoracic spinal canal metastasis with no clinical primary foci: A report of a rare case and review of the literature. Oncology Letters 2015; 10(4): 2333 doi: 10.3892/ol.2015.3569
|
| 151 |
Israa T. Ismail, Oliver Fiehn, Ashraf Elfert, Marwa Helal, Ibrahim Salama, Hala El-Said. Sugar Alcohols Have a Key Role in Pathogenesis of Chronic Liver Disease and Hepatocellular Carcinoma in Whole Blood and Liver Tissues. Cancers 2020; 12(2): 484 doi: 10.3390/cancers12020484
|
| 152 |
Samar Samir Youssef, Asmaa Elfiky, Mohamed M Nabeel, Hend Ibrahim Shousha, Tamer Elbaz, Dalia Omran, Mohammad Saeed Marie, Mohammad A Elzahry, Amr Abul-Fotouh, Ahmed Hashem, Mohamed F Guda, Ashraf O Abdelaziz. Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians. World Journal of Hepatology 2022; 14(8): 1562-1575 doi: 10.4254/wjh.v14.i8.1562
|
| 153 |
A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evaluate for potential 177Lu-PSMA therapy. Annals of Nuclear Medicine 2024; 38(2): 103 doi: 10.1007/s12149-023-01876-3
|
| 154 |
Guang Song, Hong-Xia Cao, Shao-Xin Yao, Cang-Tuo Li. Abnormal expression of WIF1 in hepatocellular carcinoma cells and its regulating effect on invasion and metastasis factors of TIMP-3 and caveolin-1 of hepatocellular carcinoma. Asian Pacific Journal of Tropical Medicine 2015; 8(11): 958 doi: 10.1016/j.apjtm.2015.10.007
|
| 155 |
Hussein Aldayyeni, Ahmed Hjazi, Sana Shahab, Jitendra Gupta, Hashem O. Alsaab, Yaseen Hasan Motea, Adeeb Abdulally Abdulhussien alazbjee, Rosario Mireya Romero-Parra, Rasha Fadhel Obaid, Beneen M. Hussien, Seyed Reza Hosseini-Fard. Functions, mechanisms, and clinical applications of lncRNA LINC00857 in cancer pathogenesis. Human Cell 2023; 36(5): 1656 doi: 10.1007/s13577-023-00936-0
|
| 156 |
Chunhui Zhou, Zhen Chen, Changli Peng, Changyong Chen, Haiping Li. Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A. Cancer Biotherapy and Radiopharmaceuticals 2021; 36(2): 211 doi: 10.1089/cbr.2019.3271
|
| 157 |
Gan Qiao, Huanli Xu, Cong Li, Xiao Li, Ammad Farooqi, Yuming Zhao, Xiaohui Liu, Ming Liu, Dimitrios Stagos, Xiukun Lin. Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma. International Journal of Molecular Sciences 2018; 19(10): 3060 doi: 10.3390/ijms19103060
|
| 158 |
Keyur Patel, Ryan Lamm, Peter Altshuler, Hien Dang, Ashesh P. Shah. Hepatocellular Carcinoma—The Influence of Immunoanatomy and the Role of Immunotherapy. International Journal of Molecular Sciences 2020; 21(18): 6757 doi: 10.3390/ijms21186757
|
| 159 |
Francesca Pezzuto, Luigi Buonaguro, Franco Buonaguro, Maria Tornesello. The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2018; 19(4): 1007 doi: 10.3390/ijms19041007
|
| 160 |
Yu Akazawa, Toshihiro Suzuki, Toshiaki Yoshikawa, Shoichi Mizuno, Yasunari Nakamoto, Tetsuya Nakatsura. Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma. World Journal of Meta-Analysis 2019; 7(3): 80-95 doi: 10.13105/wjma.v7.i3.80
|
| 161 |
Abdullah Ahmed Gibriel, Amany Mohamed Al-Anany, Mohamed Ali Ezz Al-Arab, Hassan Mohamed Elsaid Azzazy. Investigating circulatory microRNA expression profiles in Egyptian patients infected with hepatitis C virus mediated hepatic disorders. Meta Gene 2020; 26: 100792 doi: 10.1016/j.mgene.2020.100792
|
| 162 |
Lichuan Wu, Shuaibing Liu, Jinrui Wei, Dong Li, Xu Liu, Jianyi Wang, Lisheng Wang. Synthesis and biological evaluation of matrine derivatives as anti-hepatocellular cancer agents. Bioorganic & Medicinal Chemistry Letters 2016; 26(17): 4267 doi: 10.1016/j.bmcl.2016.07.045
|
| 163 |
Shan-Na Zhao, Ling-Ling Liu, Zhi-Ping Lv, Xiao-Hua Wang, Cheng-Hong Wang. Network analysis of HBV- and HCV-induced hepatocellular carcinoma based on Random Forest and Monte Carlo cross-validation. Molecular Medicine Reports 2017; 16(3): 2411 doi: 10.3892/mmr.2017.6861
|
| 164 |
Esam M. Aboubakr, Ashraf Taye, Omar M. Aly, Amira M. Gamal-Eldeen, Mohamed A. El-Moselhy. Enhanced anticancer effect of Combretastatin A-4 phosphate when combined with vincristine in the treatment of hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2017; 89: 36 doi: 10.1016/j.biopha.2017.02.019
|
| 165 |
Hongping Lu, Ming Han, Xiaoxue Yuan, Kelbinur Tursun, Yu Zhang, Yaru Li, Zhongshu Li, Shenghu Feng, Li Zhou, Zhipeng Pan, Qi Wang, Kai Han, Shunai Liu, Jun Cheng. Role of IL‐6‐mediated expression of NS5ATP9 in autophagy of liver cancer cells. Journal of Cellular Physiology 2018; 233(12): 9312 doi: 10.1002/jcp.26343
|
| 166 |
E-Na Qian, Shuang-Yin Han, Song-Ze Ding, Xun Lv. Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma. Cancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0332-3
|
| 167 |
Kai Ding, Yannian Liao, Dinghao Gong, Xin Zhao, Wu Ji. Effect of long non-coding RNA H19 on oxidative stress and chemotherapy resistance of CD133+ cancer stem cells via the MAPK/ERK signaling pathway in hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2018; 502(2): 194 doi: 10.1016/j.bbrc.2018.05.143
|
| 168 |
Vania Cruz-Ramón, Paulina Chinchilla-López, Oscar Ramírez-Pérez, Xingshun Qi, Nahum Méndez-Sánchez. The Changing Face of the Diagnosis of Chronic and Malignant Liver Diseases: Potential New Biomarkers. Annals of Hepatology 2018; 17(1): 14 doi: 10.5604/01.3001.0010.7531
|
| 169 |
Elisa Feller Gonçalves da Silva, Kelly Goulart Lima, Gabriele Catyana Krause, Gabriela Viegas Haute, Leonardo Pedrazza, Anderson Velasque Catarina, Rodrigo Benedetti Gassen, Bruno de Souza Basso, Henrique Bregolin Dias, Carolina Luft, Maria Claudia Rosa Garcia, Bruna Pasqualotto Costa, Géssica Luana Antunes, Luiz Augusto Basso, Márcio Vinícius Fagundes Donadio, Pablo Machado, Jarbas Rodrigues de Oliveira. CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence. Investigational New Drugs 2020; 38(6): 1653 doi: 10.1007/s10637-020-00941-2
|
| 170 |
Hongwei Zhao, Yubao Zhang, Jianmin Sun, Chao Zhan, Liang Zhao. Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2016; 23(5): 237 doi: 10.3727/096504016X14562725373671
|
| 171 |
Zhen Zeng, Jinghui Dong, Yinyin Li, Zheng Dong, Ze Liu, Jiagan Huang, Yonggang Wang, Yunhuan Zhen, Yinying Lu. The expression level and diagnostic value of microRNA-22 in HCC patients. Artificial Cells, Nanomedicine, and Biotechnology 2020; 48(1): 683 doi: 10.1080/21691401.2019.1703723
|